One of the major challenges for nanoparticles to be used as the drug/gene delivery phfform is their tendency to aggregate in electrolyte solution (physiological enviroment).The increased particle size after aggregation reduces the cellular uptake rate of nanocarriers [1],and increases inflammatory responses [2].Particle aggregation may also cause blood vessel clotting when being injected intravenously.